Other
Neck Pain
17
Pipeline Programs↗
15
Active Trials↗
10
Companies Involved↗
Neck pain is an emerging landscape with 17 programs across 10 companies. The most active players are Astellas, Averitas Pharma, Inc., Roche. 5 therapies are approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical6
Phase 1
No programs
Phase 25
Analysis
Trial Status
36
clinical trials
Completed17 · 47%
Recruiting7 · 19%
Not yet recruiting5 · 14%
Unknown status3 · 8%
Active, not recruiting2 · 6%
Withdrawn1 · 3%
Other1 · 3%
Clinical Trials
Trial Activity
36 trials
Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain
Recruiting·—·N/A·NCT07058636·60 enrolled
Comparison of ERGON Therapy With and Without Muscle Energy Technique in Patients With Mechanical Neck Pain: A Randomized Clinical Trial
Active, not recruiting·University of Management and Technology Sialkot Pakistan·Preclinical·NCT07672028·42 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)